Covis Pharmaceuticals Inc
Covis Pharma, founded in 2011 and backed by Cerberus Capital Management, is a global specialty pharmaceutical company headquartered in Luxembourg, focused on providing therapeutic solutions for patients with life-threatening conditions and chronic illnesses across 50 countries. With a robust product portfolio that includes well-known medications like Alvesco and Tudorza, Covis aims to deliver affordable and therapeutically equivalent medications to improve patient lives.
Led by a seasoned management team, Covis Pharma is recognized as a preferred partner for world-class pharmaceutical companies and contract manufacturing organizations, highlighting its commitment to operational excellence. The company's strategic acquisitions, including those from AMAG Pharmaceuticals and AstraZeneca, further strengthen its position in the global healthcare market.
Generated from the website